GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Modern Diagnostic & Research Centre Ltd

Modern Diagnostic: Board Approves Fund Utilization, Addresses System Faults

BOARD ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 13 May 2026, 12:06 PM IST  ·  BSE ID: b13bd932-c8d5-4a3e-be01-c5bc1fcef8cf
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board approved using funds for working capital and discussed fixing recent system shutdowns.
🤖 AI Summary
  • Board approved extending time for utilizing net issue proceeds and project completion as per prospectus.
  • Approval granted for utilizing General Corporate Purpose funds towards working capital requirements.
  • Discussion occurred regarding temporary hardware and software system faults leading to shutdowns.
  • Systems affected by faults were subsequently restored and recovered, as discussed by the Board.
  • Board meeting commenced at 11:03 A.M. and concluded at 11:17 A.M. on May 13, 2026.
🏢 How This Affects the Company
📈
Business Impact
The approval for extending project completion time and utilizing general corporate funds for working capital provides operational flexibility for ongoing projects and daily business.
💰
Financial Impact
The re-allocation of General Corporate Purpose funds to working capital requirements influences the company's liquidity management and cash flow for routine operations.
⚙️
Operational Impact
The discussion and resolution of hardware and software system faults directly address operational stability, ensuring continuity of core business functions.
⚠️
Risk Impact
Addressing system faults mitigates operational disruption risks, while the extension for project completion and fund utilization influences execution and financial risks.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this filing.
👤
Who Is Affected
All shareholders are affected as the board's decisions influence the company's operational and financial strategy regarding project execution and fund management.
🔍
Management Signal
Management is addressing project timelines, capital allocation, and operational stability by approving fund re-allocation and resolving system issues.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Next financial results filing — observe impact of working capital fund utilization.
Future disclosures on project completion status — track updated timelines.
Any further disclosures regarding system upgrades or recurring technical issues.
MEDIUM RISK Project delays, fund re-allocation, and system faults indicate operational and execution risks.
💡 Investor Takeaway
Modern Diagnostic & Research Centre Ltd's Board approved extending timelines for net issue proceeds utilization and project completion. General Corporate Purpose funds can now be used for working capital. The Board also discussed and resolved temporary hardware and software system shutdowns, which have been restored.
⚖️ Strengths & Concerns

✅ Positives

  • Board's timely discussion and resolution of hardware and software system faults indicates proactive operational management.
  • Flexibility in fund utilization, including working capital, supports business continuity and resource allocation efficiency.

⚠️ Concerns

  • The necessity to extend project completion time and fund utilization indicates potential delays or revised plans from original prospectus.
  • Occurrence of hardware and software system faults highlights inherent operational risks related to technical infrastructure stability.
📅 Company Track Record
No previous filings were found for Modern Diagnostic & Research Centre Ltd (BSE: 544673), indicating a limited public track record available from recent BSE disclosures.

Based on publicly available historical data. For context only.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.

Live IPO, GMP and market updates on Telegram

IPO open and close dates, grey market premium moves, subscription figures, allotment and listing days, and the market updates worth knowing about, posted on the channel as they happen.

Join the channel